Demystifying proteins and improving the efficacy of brain tumour diagnostics and treatment are going to be in the focus of the first winners of the TEAM-TECH Core Facility programme.
Prof. dr hab. Michał Dadlez from the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences is an expert in proteomics, a science exploring cellular proteins. One of the techniques used to gain an understanding of the identity, quantity and structure of proteins is mass spectrometry. The goal of the ?Mass spectrometry for the analysis of biopharmaceuticals? project is to improve this technology.
Prof. dr hab. Bożena Kamińska-Kaczmarek of the Nencki Institute of Experimental Biology, Polish Academy of Sciences is convinced that malignant brain tumours can be diagnosed and treated more effectively than they currently are. To this end, she wants to create a specialised platform for comprehensive diagnostics and personalised treatment in neuro-oncology, which will still be friendly to the average user.
Both projects have been awarded funding under the TEAM-TECH Core Facility, a programme financed in the framework of the Smart Growth Operational Programme, with the objective to create or develop a service with the use of the available research apparatus. The expected outcome of the programme is to create uniform rules of access to infrastructure for all interested users.
Another application round in TEAM-TECH Core Facility and Core-Facility Plus programmes has been opened on 1 August 2017. The round will close on 2 October, and the financial envelope committed is PLN 25 million.
Learn more about the projects of the winners of TEAM-TECH Core Facility:
Mass spectrometry for the analysis of biopharmaceuticals
The timeline of calls for applications in the Smart Growth Operational Programme competitions is available here: LINK
More about the TEAM-TECH Core Facility programme
More about the TEAM-TECH Core Facility Plus programme
Photo: Prof. dr hab. Michał Dadlez, photo by OneHD